134 related articles for article (PubMed ID: 16353673)
1. The capability of glucose toxicity on severe type 2 diabetes.
Hsieh CH; Hung YJ; He CT; Lee CH; Hung SC; Wang YK; Kuo SW; Pei D
Endocr Res; 2005; 31(2):149-58. PubMed ID: 16353673
[TBL] [Abstract][Full Text] [Related]
2. Ameliorated pancreatic β cell dysfunction in type 2 diabetic patients treated with a sodium-glucose cotransporter 2 inhibitor ipragliflozin.
Takahara M; Shiraiwa T; Matsuoka TA; Katakami N; Shimomura I
Endocr J; 2015; 62(1):77-86. PubMed ID: 25328035
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy.
Chen HS; Wu TE; Jap TS; Hsiao LC; Lee SH; Lin HD
Diabetes Care; 2008 Oct; 31(10):1927-32. PubMed ID: 18556343
[TBL] [Abstract][Full Text] [Related]
4. The effect of testosterone supplement on insulin sensitivity, glucose effectiveness, and acute insulin response after glucose load in male type 2 diabetics.
Lee CH; Kuo SW; Hung YJ; Hsieh CH; He CT; Yang TC; Lian WC; Chyi-Fan S; Pei D
Endocr Res; 2005; 31(2):139-48. PubMed ID: 16353672
[TBL] [Abstract][Full Text] [Related]
5. Defining and characterizing the progression of type 2 diabetes.
Fonseca VA
Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S151-6. PubMed ID: 19875543
[No Abstract] [Full Text] [Related]
6. Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes.
Elder DA; Woo JG; D'Alessio DA
Pediatr Diabetes; 2010 Aug; 11(5):314-21. PubMed ID: 19961550
[TBL] [Abstract][Full Text] [Related]
7. Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects.
Walker M; Mari A; Jayapaul MK; Bennett SM; Ferrannini E
Diabetologia; 2005 Dec; 48(12):2470-6. PubMed ID: 16261308
[TBL] [Abstract][Full Text] [Related]
8. Marked recovery from glucotoxicity of β-cell function after medical nutrition therapy without pharmacotherapy in type 2 diabetic outpatients with extreme hyperglycemia: a pilot retrospective study.
Takahara M; Shiraiwa T; Katakami N; Matsuoka TA; Shimomura I
Endocr J; 2017 Nov; 64(11):1125-1129. PubMed ID: 28845026
[TBL] [Abstract][Full Text] [Related]
9. Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes.
Rathmann W; Strassburger K; Bongaerts B; Bobrov P; Kuss O; Müssig K; Markgraf DF; Szendroedi J; Herder C; Roden M;
Diabetes Obes Metab; 2017 Jun; 19(6):866-873. PubMed ID: 28127851
[TBL] [Abstract][Full Text] [Related]
10. Determining pancreatic β-cell compensation for changing insulin sensitivity using an oral glucose tolerance test.
Solomon TP; Malin SK; Karstoft K; Knudsen SH; Haus JM; Laye MJ; Pedersen M; Pedersen BK; Kirwan JP
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E822-9. PubMed ID: 25184989
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the influence of vildagliptin on model-assessed -cell function in patients with type 2 diabetes and mild hyperglycemia.
Mari A; Scherbaum WA; Nilsson PM; Lalanne G; Schweizer A; Dunning BE; Jauffret S; Foley JE
J Clin Endocrinol Metab; 2008 Jan; 93(1):103-9. PubMed ID: 17925336
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fasting capillary glucose variability between insulin glargine and NPH.
Mu P; Lu H; Zhang G; Chen Y; Fu J; Wang M; Shu J; Zeng L
Diabetes Res Clin Pract; 2011 Jan; 91(1):e4-7. PubMed ID: 20970870
[TBL] [Abstract][Full Text] [Related]
13. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.
Osei K; Gaillard T; Schuster DP
Diabetes Care; 1997 Mar; 20(3):396-404. PubMed ID: 9051394
[TBL] [Abstract][Full Text] [Related]
14. Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes.
Gastaldelli A; Casolaro A; Pettiti M; Nannipieri M; Ciociaro D; Frascerra S; Buzzigoli E; Baldi S; Mari A; Ferrannini E
Clin Pharmacol Ther; 2007 Feb; 81(2):205-12. PubMed ID: 17259945
[TBL] [Abstract][Full Text] [Related]
15. Insulin sensitivity, and β-cell function in relation to hemoglobin A1C.
Marini MA; Frontoni S; Succurro E; Arturi F; Sciacqua A; Hribal ML; Perticone F; Sesti G
Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):27-33. PubMed ID: 23601331
[TBL] [Abstract][Full Text] [Related]
16. The Dual Amylin- and Calcitonin-Receptor Agonist KBP-042 Works as Adjunct to Metformin on Fasting Hyperglycemia and HbA1c in a Rat Model of Type 2 Diabetes.
Hjuler ST; Gydesen S; Andreassen KV; Karsdal MA; Henriksen K
J Pharmacol Exp Ther; 2017 Jul; 362(1):24-30. PubMed ID: 28438778
[TBL] [Abstract][Full Text] [Related]
17. Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese.
Oka R; Yagi K; Sakurai M; Nakamura K; Moriuchi T; Miyamoto S; Nohara A; Kawashiri MA; Takeda Y; Yamagishi M
Endocr J; 2012; 59(1):55-64. PubMed ID: 22068110
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hyperglycaemia in newly diagnosed diabetic patients is associated with a reduction in oxidative stress and improvement in β-cell function.
Acharya JD; Pande AJ; Joshi SM; Yajnik CS; Ghaskadbi SS
Diabetes Metab Res Rev; 2014 Oct; 30(7):590-8. PubMed ID: 24459082
[TBL] [Abstract][Full Text] [Related]
19. Cadmium exposure in relation to insulin production, insulin sensitivity and type 2 diabetes: a cross-sectional and prospective study in women.
Barregard L; Bergström G; Fagerberg B
Environ Res; 2013 Feb; 121():104-9. PubMed ID: 23261793
[TBL] [Abstract][Full Text] [Related]
20. The effect of glycaemic control on the quantitative characteristics of retinopathy lesions in patients with type 2 diabetes mellitus: 10-year follow-up study.
Kalesnykiene V; Sorri I; Voutilainen R; Uusitupa M; Niskanen L; Uusitalo H
Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):335-41. PubMed ID: 19043734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
